Flatiron Health is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, Flatiron provides technology and services to support patient care and make every person's story count.
The company partners with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world. Its vision is to build a world where technology and science close the gap between care and research.
Founded in 2012, Flatiron became an independent affiliate of the Roche Group in 2018. It has expanded globally with subsidiaries in Japan, Germany, and the United Kingdom, collaborating with hospitals and health networks tailored to each market's needs.
